Trilogy, Inc., Versata Enterprises, Inc. (Selectica v. Versata)

Represented a provider of enterprise software solutions in the Delaware Chancery Court and Delaware Supreme Court in the trial and appeal of the first case to challenge the validity of a 4.99% shareholder rights plan (or net operating loss “poison pill”), arising from the triggering of the pill and the subsequent dilution of the investor’s holdings.

Participating Lawyers

Sort By

Email Disclaimer